SIMPLER MINI DENTAL IMPLANT: SM 3002 2.5 X 10MM, SM 3003 2.5 X 13MM, SM 3004 2.5 X 15MM
Device Facts
| Record ID | K073645 |
|---|---|
| Device Name | SIMPLER MINI DENTAL IMPLANT: SM 3002 2.5 X 10MM, SM 3003 2.5 X 13MM, SM 3004 2.5 X 15MM |
| Applicant | 659543 BC , Ltd. |
| Product Code | DZE · Dental |
| Decision Date | Oct 21, 2008 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 872.3640 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
The Transitional Implants are designed for temporary use in edentulous sites. The primary purpose is to provide provisional prosthetic devices to protect the permanent implants from premature loading during the healing period. They are used to support bridges and dentures. Additional uses are inter-radicular transitional applications, immediate splinting stability, full and partial edentulism and using minimally invasive surgical interventions. The target population is determined when there is inadequate bone for wider implants as well as for patients wishing immediate functional loading. The transitionals are to be used in a clinical site by a qualified dentist experienced in placing dental implants.
Device Story
Simpler Mini Dental Implants are transitional, one-piece endosseous dental implants; serve as provisional artificial roots to provide immediate load support for permanent implants. Device features ball abutment at top; interfaces with rubber o-ring and keeper in prosthesis for retention. Used in clinical settings by qualified dentists. Input: surgical site preparation in edentulous patients. Output: mechanical support for provisional bridges/dentures. Benefit: protects permanent implants from premature loading during healing; provides stability in cases of inadequate bone or need for immediate function.
Clinical Evidence
No clinical data. Substantial equivalence based on bench testing, including material composition (6/4 Titanium alloy), surface treatment (grit blasted), and fatigue testing.
Technological Characteristics
Material: 6/4 Titanium alloy (90% Ti, 6% Al, 4% V). Design: One-piece, 2.5mm diameter, lengths 10mm, 13mm, 15mm. Surface: Grit blasted. Feature: Ball abutment for o-ring retention. Energy source: None (mechanical). Connectivity: None. Sterilization: Not specified.
Indications for Use
Indicated for temporary use in edentulous patients requiring provisional prosthetic support (bridges/dentures) during healing, inter-radicular applications, or immediate splinting. Suitable for patients with inadequate bone for wider implants or those desiring immediate functional loading. Contraindications: None stated.
Regulatory Classification
Identification
An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.
Special Controls
*Classification.* (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2) *Classification.* Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use; (ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads; (iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system; (iv) The device must be demonstrated to be biocompatible; (v) Sterility testing must demonstrate the sterility of the device; (vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment; (vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians; (viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and (ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.